Efficacy of Garenoxacin in Treatment of Experimental Endocarditis Due to Staphylococcus aureus or Viridans Group Streptococci

The activity of garenoxacin was investigated in rats with experimental endocarditis due to staphylococci and viridans group streptococci (VGS). The staphylococci tested comprised one ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus (MSSA) isolate (isolate 1112), one ciprof...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Entenza, José M., Vouillamoz, Jacques, Glauser, Michel P., Moreillon, Philippe
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 2004
Teme:	Experimental Therapeutics
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC310157/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14693523/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.1.86-92.2004
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!